Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1248022.RAu7ciP6m023-5oDP_Q8uSHwFl4BdoP75VAVH0M9Cqhks130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1248022.RAu7ciP6m023-5oDP_Q8uSHwFl4BdoP75VAVH0M9Cqhks130_assertion type Assertion NP1248022.RAu7ciP6m023-5oDP_Q8uSHwFl4BdoP75VAVH0M9Cqhks130_head.
- NP1248022.RAu7ciP6m023-5oDP_Q8uSHwFl4BdoP75VAVH0M9Cqhks130_assertion description "[In conclusion, NAM may be used as a chemo? or radiosensitizing agent regardless of the BRCA1 status in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1248022.RAu7ciP6m023-5oDP_Q8uSHwFl4BdoP75VAVH0M9Cqhks130_provenance.
- NP1248022.RAu7ciP6m023-5oDP_Q8uSHwFl4BdoP75VAVH0M9Cqhks130_assertion evidence source_evidence_literature NP1248022.RAu7ciP6m023-5oDP_Q8uSHwFl4BdoP75VAVH0M9Cqhks130_provenance.
- NP1248022.RAu7ciP6m023-5oDP_Q8uSHwFl4BdoP75VAVH0M9Cqhks130_assertion SIO_000772 25504347 NP1248022.RAu7ciP6m023-5oDP_Q8uSHwFl4BdoP75VAVH0M9Cqhks130_provenance.
- NP1248022.RAu7ciP6m023-5oDP_Q8uSHwFl4BdoP75VAVH0M9Cqhks130_assertion wasDerivedFrom befree-2016 NP1248022.RAu7ciP6m023-5oDP_Q8uSHwFl4BdoP75VAVH0M9Cqhks130_provenance.
- NP1248022.RAu7ciP6m023-5oDP_Q8uSHwFl4BdoP75VAVH0M9Cqhks130_assertion wasGeneratedBy ECO_0000203 NP1248022.RAu7ciP6m023-5oDP_Q8uSHwFl4BdoP75VAVH0M9Cqhks130_provenance.